Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / VINC - Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 | Benzinga


VINC - Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 | Benzinga

  • PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (NASDAQ:VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego, CA, from April 5 – 10, 2024. Vincerx will also share clinical data for VIP236 at the conference.

    "We are extremely pleased to highlight the continued development of our next-generation VersAptx™ bioconjugation platform in these three abstract/poster presentations," said Ahmed Hamdy, M.D., Chief Executive Officer of Vincerx. "In addition to the preclinical results of our VersAptx platform, our SMDC poster (#3197) will also present, for the first time, early clinical results for VIP236. To date, 20 patients with relapsed/refractory advanced or metastatic solid tumors have been treated with two different dosing schedules of VIP236. The poster will summarize preliminary safety, efficacy, and pharmacokinetic results from this first-in-human, dose-escalation study (NCT05712889)."

    Virtual Investor Event:

    Vincerx will host a virtual investor event featuring company management and key opinion leaders on Monday, April 8, 2024. The event will be webcast live, and details can be accessed in the Investor Calendar section of the Vincerx website on March 27, 2024. An archived replay will be available shortly after the conclusion of the live event.

    Poster presentation details:

    Title: Activity of VIP943 on AML patient-derived leukemic blasts and healthy donor-derived bone marrow hematopoietic stem cells
    Abstract Number: 629
    Session Category: Experimental and Molecular Therapeutics
    Session Title: Mechanisms of Drug Action
    Session Date and Time: Sunday, April 7, 2024, 1:30 PM – 5:30 PM PT
    Location: Poster Section 26; Poster Board Number 6
    Presented by Beatrix Stelte-Ludwig, Ph.D., Vincerx Pharma

    Title: Innovations in ADC technology platform with legumain-cleavable KSP-inhibitor payloads adaptable to various aspects of cancer biology
    Abstract Number: 2051
    Session Category: Experimental and Molecular Therapeutics
    Session Title: New Technologies  
    Session Date and Time: Monday, April 8, 2024, 9:00 AM – 12:30 PM PT
    Location: Poster Section 28; Poster Board Number 8
    Presented by Hans-Georg Lerchen, Ph.D., Vincerx Pharma

    Title: Addressing drug metabolism and pharmacokinetics (DMPK) challenges of small molecule-drug conjugates (SMDCs)
    Abstract Number: 3197
    Session Category: Experimental and Molecular Therapeutics
    Session Title: Cancer Immunotherapy and Drug Delivery
    Session Date and Time: Monday, April 8, 2024, 1:30 PM – 5:00 PM PT
    Location: Poster Section 23; Poster Board Number 14
    Presented by Anne-Sophie Rebstock, Ph.D., Vincerx Pharma

    A copy of the presentation materials can be accessed on the Investors section of the Company's website at https://investors.vincerx.com/news-events/presentations ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Vincera Pharma Inc Com
    Stock Symbol: VINC
    Market: NASDAQ
    Website: vincerx.com

    Menu

    VINC VINC Quote VINC Short VINC News VINC Articles VINC Message Board
    Get VINC Alerts

    News, Short Squeeze, Breakout and More Instantly...